CytomX Therapeutics Inc. is a biopharmaceutical company that develops innovative antibody therapeutics. With a focus on cancer treatments, the company utilizes its unique Probody™ platform to create precision therapies that target cancer cells while sparing healthy tissue. CytomX’s cutting-edge approach holds promise for personalized medicine and improved outcomes for patients.
Notification